D. W. Woolley

7.1k total citations · 1 hit paper
105 papers, 2.6k citations indexed

About

D. W. Woolley is a scholar working on Molecular Biology, Organic Chemistry and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, D. W. Woolley has authored 105 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 27 papers in Organic Chemistry and 10 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in D. W. Woolley's work include Diet, Metabolism, and Disease (6 papers), Glycosylation and Glycoproteins Research (6 papers) and Carbohydrate Chemistry and Synthesis (6 papers). D. W. Woolley is often cited by papers focused on Diet, Metabolism, and Disease (6 papers), Glycosylation and Glycoproteins Research (6 papers) and Carbohydrate Chemistry and Synthesis (6 papers). D. W. Woolley collaborates with scholars based in United States, Malaysia and Spain. D. W. Woolley's co-authors include E Shaw, R. B. Merrifield, Elliott Shaw, B. W. Gommi, John Morrow Stewart, Armin Braun, G. Schaffner, Spyridon G.A. Alivisatos, Ross B. Pringle and George L. Tritsch and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

D. W. Woolley

104 papers receiving 2.1k citations

Hit Papers

A BIOCHEMICAL AND PHARMACOLOGICAL SUGGESTION ABOUT CERTAI... 1954 2026 1978 2002 1954 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. W. Woolley United States 27 1.0k 584 507 250 189 105 2.6k
N. Narasimhachari United States 24 504 0.5× 440 0.8× 207 0.4× 257 1.0× 181 1.0× 136 1.9k
Carl C. Pfeiffer United States 23 503 0.5× 498 0.9× 128 0.3× 125 0.5× 164 0.9× 85 1.8k
Bryan B. Molloy United States 26 921 0.9× 1.2k 2.0× 394 0.8× 129 0.5× 276 1.5× 62 2.3k
A. Horita United States 32 739 0.7× 1.3k 2.2× 242 0.5× 225 0.9× 475 2.5× 119 2.6k
Creed W. Abell United States 24 919 0.9× 722 1.2× 236 0.5× 61 0.2× 160 0.8× 79 2.2k
Peter G. Waser Switzerland 27 880 0.9× 1.0k 1.8× 261 0.5× 66 0.3× 281 1.5× 168 2.6k
Francis P. Miller United States 16 568 0.6× 932 1.6× 373 0.7× 89 0.4× 188 1.0× 23 1.9k
Merton Sandler United Kingdom 28 752 0.7× 580 1.0× 149 0.3× 159 0.6× 313 1.7× 57 2.4k
Louis Shuster United States 37 1.3k 1.3× 1.4k 2.4× 125 0.2× 285 1.1× 576 3.0× 95 3.9k
J. M. van Rossum Netherlands 20 986 1.0× 625 1.1× 148 0.3× 63 0.3× 504 2.7× 46 2.2k

Countries citing papers authored by D. W. Woolley

Since Specialization
Citations

This map shows the geographic impact of D. W. Woolley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. W. Woolley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. W. Woolley more than expected).

Fields of papers citing papers by D. W. Woolley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. W. Woolley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. W. Woolley. The network helps show where D. W. Woolley may publish in the future.

Co-authorship network of co-authors of D. W. Woolley

This figure shows the co-authorship network connecting the top 25 collaborators of D. W. Woolley. A scholar is included among the top collaborators of D. W. Woolley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. W. Woolley. D. W. Woolley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Woolley, D. W. & Tom Clements. (1997). Family medicine residentsʼ and community physiciansʼ concerns about patient truthfulness. Academic Medicine. 72(2). 155–7. 3 indexed citations
2.
Stewart, John Morrow & D. W. Woolley. (1964). Antimetabolites of Mevalonic Acid. II. Inhibition of Ergosterol Synthesis in Yeast*. Biochemistry. 3(12). 1998–2004. 3 indexed citations
3.
Woolley, D. W., et al.. (1963). Alteration in Learning Ability Caused by Changes in Cerebral Serotonin and Catechol Amines. Science. 139(3555). 610–611. 47 indexed citations
4.
Jones, Kenneth M. & D. W. Woolley. (1962). PEPTIDES REQUIRED FOR THE GROWTH OF LACTOBACILLUS BULGARICUS. Journal of Bacteriology. 83(4). 797–801. 7 indexed citations
5.
Tritsch, George L. & D. W. Woolley. (1960). The Synthesis of L-Leucyl-L-valyl-L-cysteinylglycyl- L-glutamyl-L-arginine, an Insulin Fragment with Strepogenin Activity1. Journal of the American Chemical Society. 82(11). 2787–2793. 18 indexed citations
6.
Woolley, D. W.. (1959). Highly potent antimetabolites of serotonin with little serotonin-like action. Biochemical Pharmacology. 3(1). 51–59. 7 indexed citations
7.
Tritsch, George L. & D. W. Woolley. (1958). The Isolation and Determination of Structure of Peptides with Strepogenin Activity. II. The Disulfide of Leucylvalylcysteinylglycylglutamylarginine from Insulin1. Journal of the American Chemical Society. 80(6). 1490–1493. 9 indexed citations
8.
Shaw, E & D. W. Woolley. (1957). Indole Carboxamidines and Aminomethylindoles as Antimetabolites of Serotonin. Journal of the American Chemical Society. 79(13). 3561–3564. 6 indexed citations
9.
Woolley, D. W.. (1956). Arzneimittel und Antimetaboliten. Naunyn-Schmiedeberg s Archives of Pharmacology. 228(1-2). 68–81. 2 indexed citations
10.
Woolley, D. W., et al.. (1956). METHYLSEROTONINS AS POTENT ANTIMETABOLITES OF SEROTONIN ACTIVE BOTH IN VITRO AND IN VIVO. Journal of Pharmacology and Experimental Therapeutics. 116(2). 164–176. 24 indexed citations
11.
Merrifield, R. B. & D. W. Woolley. (1955). Isolation and determination of structure of a peptide with strepogenin activity. Archives of Biochemistry and Biophysics. 56(1). 265–266. 3 indexed citations
12.
Woolley, D. W.. (1955). PRODUCTION OF ABNORMAL (PSYCHOTIC?) BEHAVIOR IN MICE WITH LYSERGIC ACID DIETHYLAMIDE, AND ITS PARTIAL PREVENTION WITH CHOLINERGIC DRUGS AND SEROTONIN. Proceedings of the National Academy of Sciences. 41(6). 338–344. 39 indexed citations
13.
Woolley, D. W. & E Shaw. (1954). Some Neurophysiological Aspects of Serotonin. BMJ. 2(4880). 122–126. 135 indexed citations
14.
Shaw, E & D. W. Woolley. (1954). PHARMACOLOGICAL PROPERTIES OF SOME ANTIMETABOLITES OF SEROTONIN HAVING UNUSUALLY HIGH ACTIVITY ON ISOLATED TISSUES. Journal of Pharmacology and Experimental Therapeutics. 111(1). 43–53. 23 indexed citations
15.
Woolley, D. W. & E Shaw. (1952). SOME ANTIMETABOLITES OF SEROTONIN AND THEIR POSSIBLE APPLICATION TO THE TREATMENT OF HYPERTENSION. Journal of the American Chemical Society. 74(11). 2948–2949. 19 indexed citations
16.
Woolley, D. W., Ross B. Pringle, & Armin Braun. (1952). ISOLATION OF THE PHYTOPATHOGENIC TOXIN OF PSEUDOMONAS TABACI, AN ANTAGONIST OF METHIONINE. Journal of Biological Chemistry. 197(1). 409–417. 64 indexed citations
17.
Woolley, D. W., et al.. (1952). RELATIONSHIP OF CHEMICAL STRUCTURE TO ANTIBACTERIAL ACTIVITY AMONG ANALOGUES OF DIMETHYLDIAMINOBENZENE. Journal of Biological Chemistry. 194(2). 729–746. 15 indexed citations
18.
Shaw, Elliott & D. W. Woolley. (1952). IMIDAZO-1,2,3-TRIAZINES AS SUBSTRATES AND INHIBITORS FOR XANTHINE OXIDASE. Journal of Biological Chemistry. 194(2). 641–654. 38 indexed citations
19.
Woolley, D. W., et al.. (1951). SELECTIVE TOXICITY OF 1,2-DICHLORO-4,5-DIAMINOBENZENE: ITS RELATION TO REQUIREMENTS FOR RIBOFLAVIN AND VITAMIN B12. The Journal of Experimental Medicine. 93(1). 13–24. 30 indexed citations
20.
Woolley, D. W.. (1951). AN ENZYMATIC STUDY OF THE MODE OF ACTION OF PYRITHIAMINE (NEOPYRITHIAMINE). Journal of Biological Chemistry. 191(1). 43–54. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026